Endovascular Stroke Treatment Today

References

1. 1.↵
   NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Heuschmann PU,
   2. Berger K,
   3. Misselwitz B,
   4. et al

   . Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003;34:1106–13

   Abstract/FREE Full Text
3. 3.↵
   1. Schumacher HC,
   2. Bateman BT,
   3. Boden-Albala B,
   4. et al

   . Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med 2007;50:99–107

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Weimar C,
   2. Kraywinkel K,
   3. Maschke M,
   4. et al

   . Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator. Cerebrovasc Dis 2006;22:429–31

   CrossRefPubMed
5. 5.↵
   1. Albers GW,
   2. Thijs VN,
   3. Wechsler L,
   4. et al.

   , for the DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 2006;60:508–17

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Davis SM,
   2. Donnan GA,
   3. Parsons MW,
   4. et al.

   , for the EPITHET Investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309. Epub 2008 Feb 28

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Furlan AJ,
   2. Eyding D,
   3. Albers GW,
   4. et al.

   , for the DEDAS Investigators. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–31

   Abstract/FREE Full Text
8. 8.↵
   1. Hacke W,
   2. Albers G,
   3. Al-Rawi Y,
   4. et al.

   , for the DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73

   Abstract/FREE Full Text
9. 9.↵
   1. Warach S

   , for the DIAS-2 Study Group. Clinical benefit of desmoteplase treatment in patients with moderate to severe stroke: further results of the DIAS-2 Study. In: Proceedings of the International Stroke Conference, New Orleans, Louisiana. 2 21, 2008
10. 10.↵
    1. Mishra NK,
    2. Albers GW,
    3. Davis SM,
    4. et al

    . Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010;41:e25–33. Epub 2009 Nov 19

    Abstract/FREE Full Text
11. 11.↵
    1. Donnan GA,
    2. Baron JC,
    3. Ma H,
    4. et al

    . Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009;8:261–69

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Zivin JA,
    2. Fisher M,
    3. De Girolami U,
    4. et al

    . Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 1985;230:1289–92

    Abstract/FREE Full Text
13. 13.↵
    1. Papadakis M,
    2. Buchan AM

    . Translational vehicles for neuroprotection. Biochem Soc Trans 2006;34:1318–22

    CrossRefPubMed
14. 14.↵
    1. Qureshi Al,
    2. Ali Z,
    3. Suri MF,
    4. et al

    . Intra-arterial third generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001;49:41–48, discussion 48–50

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C,
    4. et al

    . Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C,
    4. et al

    . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–51

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Hacke W,
    2. Kaste M,
    3. Bluhmki E,
    4. et al

    . Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–29

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Wahlgren N,
    2. Ahmed N,
    3. Davalos A,
    4. et al.

    , for the SITS Investigators. Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303–09

    CrossRefPubMedWeb of Science
19. 19.↵
    IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904–11. Epub 2004 Mar 11

    Abstract/FREE Full Text
20. 20.↵
    1. Flaherty ML,
    2. Woo D,
    3. Kissela B,
    4. et al

    . Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005;64:386–88

    Abstract/FREE Full Text
21. 21.↵
    1. Lee KY,
    2. Kim DI,
    3. Kim SH,
    4. et al

    . Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:1470–75

    Abstract/FREE Full Text
22. 22.↵
    1. Lewandowski C,
    2. Frankel M,
    3. Tomsick T,
    4. et al.

    , for the EMS Bridging Trial Investigators. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598–605

    Abstract/FREE Full Text
23. 23.↵
    1. Zaidat OO,
    2. Suarez JI,
    3. Santillan C,
    4. et al

    . Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821–26

    Abstract/FREE Full Text
24. 24.↵
    1. Del Zoppo GJ,
    2. Higashida RT,
    3. Furlan AJ,
    4. et al

    . PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke—PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4–11

    Abstract/FREE Full Text
25. 25.↵
    1. Furlan A,
    2. Higashida R,
    3. Wechsler L,
    4. et al

    . Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study—a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Smith W,
    2. Sung G,
    3. Saver J,
    4. et al

    . Mechanical thrombectomy for acute ischemic stroke: final results of the Multi Merci trial. Stroke 2008;39:1205–12. Epub 2008 Feb 28

    Abstract/FREE Full Text
27. 27.↵
    1. Mattle HP,
    2. Arnold M,
    3. Georgiadis D,
    4. et al

    . Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379–83

    Abstract/FREE Full Text
28. 28.↵
    The IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II study. Stroke 2007;38:2127–35. Epub 2007 May 24

    Abstract/FREE Full Text
29. 29.↵
    1. Tomsick T,
    2. Broderick J,
    3. Carrozella J,
    4. et al.

    , for the Interventional Management of Stroke II Investigators. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008;29:582–87

    Abstract/FREE Full Text
30. 30.↵
    1. Mazighi M,
    2. Serfaty JM,
    3. Labreuche J,
    4. et al

    . Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802–09

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Gobin YP,
    2. Starkman S,
    3. Duckwiler GR,
    4. et al

    . Merci 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004;35:2848–54

    Abstract/FREE Full Text
32. 32.↵
    1. Brekenfeld C,
    2. Schroth G,
    3. El-Koussy M,
    4. et al

    . Mechanical thromboembolectomy for acute ischemic stroke: comparison of the catch thrombectomy device and the Merci retriever in vivo. Stroke 2008;39:1213–19. Epub 2008 Feb 28

    Abstract/FREE Full Text
33. 33.↵
    1. Smith WS,
    2. Tsao JW,
    3. Billings ME,
    4. et al

    . Prognostic significance of angiographically confirmed large vessel intracranial occlusion in patients presenting with acute brain ischemia. Neurocrit Care 2006;4:14–17

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Smith WS,
    2. Sung G,
    3. Starkmann S,
    4. et al

    . Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432–38

    Abstract/FREE Full Text
35. 35.↵
    1. Smith WS

    . Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007;38:701–03

    Abstract/FREE Full Text
36. 36.↵
    1. Liebig T,
    2. Reinartz J,
    3. Hannes R,
    4. et al

    . Comparative in vitro study of five mechanical embolectomy systems: effectiveness of clot removal and risk of distal embolization. Neuroradiology 2008;50:43–52

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Bose A,
    2. Henkes H,
    3. Alfke K,
    4. et al

    . for the Penumbra Phase 1 Stroke Trial Investigators. The Penumbra system: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409–13

    Abstract/FREE Full Text
38. 38.↵
    The Penumbra Pivotal Stroke Trial Investigators. The Penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761–68. Epub 2009 Jul 9

    Abstract/FREE Full Text
39. 39.↵
    1. Grunwald IQ,
    2. Bose A,
    3. Struffert T,
    4. et al

    . Images in neurology: liposuction in mind. Arch Neurol 2009;66:800–01

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Grunwald IQ,
    2. Walter S,
    3. Papanagiotou P,
    4. et al

    . Revascularization in acute ischaemic stroke using the Penumbra system: the first single center experience. Eur J Neurol 2009;16:1210–16

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Nogueira RG,
    2. Yoo AJ,
    3. Buonanno FS,
    4. et al

    . Endovascular approaches to acute stroke. Part 2. A comprehensive review of studies and trials. AJNR Am J Neuroradiol 2009;30:859–75

    Abstract/FREE Full Text
42. 42.↵
    1. Castaño C,
    2. Dorado L,
    3. Guerrero C,
    4. et al

    . Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836–40. Epub 2010 Jun 10

    Abstract/FREE Full Text